Page 57 - EJMO-9-3

Eurasian Journal of
Medicine and Oncology NOTCH3 in CSVD and breast cancer

doi: 10.1002/path.2997 doi: 10.1111/j.1600-0463.2007.00751.x
88. Chen CY, Chen YY, Hsieh MS, et al. Expression of Notch 99. Masiero M, Minuzzo S, Pusceddu I, et al. Notch3-mediated
gene and its impact on survival of patients with resectable regulation of MKP-1 levels promotes survival of T acute
non-small cell lung cancer. J Cancer. 2017;8(7):1292-1300. lymphoblastic leukemia cells. Leukemia. 2011;25(4):588-598.
doi: 10.7150/jca.17741 doi: 10.1038/leu.2010.323.
89. Shi C, Qian J, Ma M, Zhang Y, Han B. Notch3 protein, not 100. Tang XF, Cao Y, Peng DB, et al. Overexpression of Notch3
its gene polymorphism, is associated with the chemotherapy is associated with metastasis and poor prognosis in
response and prognosis of advanced NSCLC patients. Cell osteosarcoma patients. Cancer Manag Res. 2019;11:547-559.
Physiol Biochem. 2014;34(3):743-752.
doi: 10.2147/CMAR.S185495
doi: 10.1159/000363039
101. Zhang Y, Chen B, Wang Y, et al. NOTCH3 overexpression and
90. Ikezawa Y, Sakakibara-Konishi J, Mizugaki H, et al. posttranscriptional regulation by miR-150 were associated
Inhibition of Notch and HIF enhances the antitumor effect with EGFR-TKI resistance in lung adenocarcinoma. Oncol
of radiation in Notch expressing lung cancer. Int J Clin Res. 2019;27(7):751-761.
Oncol. 2017;22(1):59-69.
doi: 10.3727/096504018X15372657298381
doi: 10.1007/s10147-016-1031-8
102. Xiu M, Wang Y, Li B, et al. The role of Notch3 signaling
91. Liu Z, Yun R, Yu X, et al. Overexpression of Notch3 and in cancer stemness and chemoresistance: Molecular
pS6 is associated with poor prognosis in human ovarian mechanisms and targeting strategies. Front Mol Biosci.
epithelial cancer. Mediators Inflamm. 2016;2016:5953498. 2021;8:694141.
doi: 10.1155/2016/5953498 doi: 10.3389/fmolb.2021.694141
92. Jung SG, Kwon YD, Song JA, et al. Prognostic significance 103. Bernasconi-Elias P, Hu T, Jenkins D, et al. Characterization
of Notch 3 gene expression in ovarian serous carcinoma. of activating mutations of NOTCH3 in T-cell acute
Cancer Sci. 2010;101(9):1977-1983. lymphoblastic leukemia and anti-leukemic activity
of NOTCH3 inhibitory antibodies. Oncogene. 2016;
doi: 10.1111/j.1349-7006.2010.01641.x
35(47):6077-6086.
93. Chen CF, Dou XW, Liang YK, et al. Notch3 overexpression
causes arrest of cell cycle progression by inducing Cdh1 doi: 10.1038/onc.2016.133
expression in human breast cancer cells. Cell Cycle. 104. Papadakos KS, Bartoschek M, Rodriguez C, et al. Cartilage
2016;15(3):432-440. oligomeric matrix protein initiates cancer stem cells through
activation of Jagged1-Notch3 signaling. Matrix Biol.
doi: 10.1080/15384101.2015.1127474
2019;81:107-121.
94. Ross AE, Marchionni L, Vuica-Ross M, et al. Gene expression
pathways of high-grade localized prostate cancer. Prostate. doi: 10.1016/j.matbio.2018.11.007
2011;71(14):1568-1577. 105. Fang CH, Lin YT, Liang CM, Liang SM. A novel C-Kit/
phospho-prohibitin axis enhances ovarian cancer stemness
doi: 10.1002/pros.21373
and chemoresistance via Notch3-PBX1 and β-catenin-
95. Danza G, Di Serio C, Ambrosio MR, et al. Notch3 is activated ABCG2 signaling. J Biomed Sci. 2020;27(1):42.
by chronic hypoxia and contributes to the progression of
human prostate cancer. Int J Cancer. 2013;133(11):2577-2588. doi: 10.1186/s12929-020-00638-x
106. Meurette O, Mehlen P. Notch signaling in the tumour
doi: 10.1002/ijc.28293
microenvironment. Cancer Cell. 2018;34(4):536-548.
96. Yeasmin S, Nakayama K, Rahman MT, et al. Expression of
nuclear Notch3 in cervical squamous cell carcinomas and its doi: 10.1016/j.ccell.2018.07.009.
association with adverse clinical outcomes. Gynecol Oncol. 107. Hanahan D, Coussens LM. Accessories to the crime:
2010;117(3):409-416. Functions of cells recruited to the tumour microenvironment.
Cancer Cell. 2012;21(3):309-322.
doi: 10.1016/j.ygyno.2010.03.004
doi: 10.1016/j.ccr.2012.02.022
97. Liu J, Fan H, Ma Y, et al. Notch1 is a 5-fluorouracil resistant
and poor survival marker in human esophagus squamous 108. Shen Q, Cohen B, Zheng W, et al. Notch shapes the innate
cell carcinomas. PLoS One. 2013;8(2):e56141. immunophenotype in breast cancer. Cancer Discov.
2017;7(11):1320-1335.
doi: 10.1371/journal.pone.0056141
doi: 10.1158/2159-8290.CD-17-0037
98. Lee SH, Jeong EG, Yoo NJ, Lee SH. Mutational analysis of
NOTCH1, 2, 3 and 4 genes in common solid cancers and 109. Tsuyada A, Chow A, Wu J, et al. CCL2 mediates cross-talk
acute leukemias. APMIS. 2007;115(12):1357-1363. between cancer cells and stromal fibroblasts that regulates

Volume 9 Issue 3 (2025) 49 doi: 10.36922/EJMO025150095